An Edman degradation of the antibiotic eremomycin aglycone produced th
e corresponding hexapeptide, which was aminoacylated with D-lysine, D-
histidine or D-tryptophan derivatives to give new heptapeptide analogs
of the eremomycin aglycone. The aminoacylation of the eremomycin agly
cone produced an octapeptide analog. The substitution of D-lysine for
the N-terminal N-methyl-D-leucine does not seriously affect the in vit
ro antibacterial properties of the eremomycin aglycone whereas the hep
tapeptides with the N-terminal D-tryptophan or D-histidine moieties an
d the octapeptide with the N-terminal D-lysine are practically devoid
of the antibacterial properties.